Europe Animal Health Key Players-Business

Who are the Europe Animal Health Market Top Companies and What are Their Offerings?

What are the Recent Developments in the Europe Animal Health Market?

• In February 2026, a commercial launch strategy update for ECOVAXXIN® MS, which is a poultry vaccine against Mycoplasma synoviae, providing active immunisation and reducing egg production losses, air sac, and foot pad lesions, was announced by ECO Animal Health Group plc. After receiving a European Commission grant, the company aims to commercialize the product across key European territories.
• In January 2026, to offer new wound care products, a collaboration between Amferia and Magnum Veterinaaria was announced. This collaboration will support the expansion of the animal-health footprint of Amferia in Europe and advance the animal wound care offerings of Magnum.

Europe Animal Health Market Value Chain Analysis

R&D

• The R&D of Europe animal health focuses on the development of advanced monoclonal antibodies, digital diagnostics tracking tools, and RNA-based livestock vaccines.
• Key players: Boehringer Ingelheim Animal Health, Zoetis Inc., MSD Animal Health.

Clinical Trials and Regulatory Approvals

• The safety, clinical efficacy, and environmental impact are evaluated in the clinical trials and regulatory approval of animal health products in Europe.
• Key players: Boehringer Ingelheim Animal Health, Zoetis Inc., MSD Animal Health.

Patient Support and Services

• The digital health tracking applications, educational portals, and 24/7 veterinary technical hotlines are provided in the patient support and services in animal health in Europe.
• Key players: Boehringer Ingelheim Animal Health, Zoetis Inc., MSD Animal Health.

Market Growth

The Europe animal health market size was estimated at USD 62.48 billion in 2025 and is predicted to increase from USD 67.45 billion in 2026 to approximately USD 134.39 billion by 2035, expanding at a CAGR of 7.96% from 2026 to 2035.